Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy of leprosy.

J Convit, S G Browne, J Languillon

    Bulletin of the World Health Organization
    |January 1, 1970
    PubMed
    Summary

    This review discusses current leprosy therapies, including sulfones like diaphenylsulfone, and newer drugs. It emphasizes long-term studies and a biochemical approach to host defenses, recommending diaphenylsulfone as the primary treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Erratum to: Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2016
    Same author

    Autologous tumor lysate/Bacillus Calmette-Guérin immunotherapy as an adjuvant to conventional breast cancer therapy.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2015
    Same author

    Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole.

    Clinical and experimental dermatology·2014
    Same author

    SPECIFIC REACTIONS OCCURRING IN THE TREATMENT OF LYMPHOGRANULOMA VENEREUM WITH IMMUNE ANIMAL SERUMS.

    The British journal of venereal diseases·2011
    Same author

    Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
    Same author

    Activation of an originally negative intracutaneous Leishmania-vaccine reaction.

    Acta medica Orientalia·2010

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Immunology

    Background:

    • Leprosy therapy has evolved, with ongoing research into effective treatments.
    • Understanding drug efficacy and host defense mechanisms is crucial for managing leprosy.
    • The lepra reaction presents a significant challenge in leprosy management.

    Purpose of the Study:

    • To review the latest developments in leprosy therapy.
    • To evaluate the efficacy and dosages of existing and emerging antileprosy drugs.
    • To discuss strategies for improving host defenses and managing leprosy reactions.

    Main Methods:

    • Literature review of current and emerging leprosy treatment options.
    • Analysis of therapeutic efficacy and dosages of various drugs, including sulfones and sulfonamides.

    Related Experiment Videos

  • Discussion of novel agents and adjunctive therapies like thalidomide.

    • Main Results:

    • Diaphenylsulfone remains the drug of choice for leprosy therapy.
    • Long-acting sulfonamides (sulfamethoxine, sulfalene) and thiambutosine show therapeutic potential.
    • Newer drugs like 4,4'-diacetyldiaminodiphenylsulfone and clofazimine are under early evaluation.
    • Thalidomide may be valuable for treating the lepra reaction.

    Conclusions:

    • Long-term studies are essential for definitive assessment of leprosy treatments.
    • A biochemical approach to correct host defenses is recommended.
    • Controlled trials are needed to further investigate promising therapeutic strategies.